Literature DB >> 12736709

The human TruB family of pseudouridine synthase genes, including the Dyskeratosis Congenita 1 gene and the novel member TRUB1.

Cinzia Zucchini1, Pierluigi Strippoli, Alessia Biolchi, Rossella Solmi, Luca Lenzi, Pietro D'Addabbo, Paolo Carinci, Luisa Valvassori.   

Abstract

A novel human gene denominated TruB pseudouridine (psi) synthase homolog 1 (E. coli) (approved symbol, TRUB1) has been identified and characterized. Spanning approximately 40 kb on chromosome 10 and including 8 exons, TRUB1 is the first described human ortholog of bacterial TruB/psi55, a gene involved in tRNA pseudouridinilation. TRUB1 gene encodes a 349-amino acid product, with a VFAVHKPKGPTSA box in positions 71-83 corresponding to motif I of the TruB family (probably involved in conserving protein structure). The TruB domain of TRUB1 lies between W104 and I255, and contains another short motif, GGTLDS AARGVLVV, including the highly conserved D residue that characterizes motif II (involved in uridine recognition and in catalytic function of psi synthases). Northern blot analysis revealed that TRUB1 mRNA is widely expressed in various human tissues (especially heart, skeletal muscle and liver). Phylogenetic analysis of the TruB domain revealed another human gene (approved symbol TRUB2) encoding a conserved TruB domain, located on human chromosome 9. Thus, the human TruB family includes at least three members: i.e. DKC1 (previously identified), TRUB1 and TRUB2. The TRUB1 and TRUB2 products could be the hitherto unidentified human tRNA psi synthases. Although TRUB1 is not highly similar to DKC1/dyskerin (whose mutations cause X-linked dyskeratosis congenita) and putatively affects tRNA rather than rRNA modification, it is the most similar human protein to dyskerin. Study of TRUB1 (and TRUB2) should facilitate understanding of the molecular mechanisms of RNA modification and the involvement of psi synthases in human pathology, including dyskeratosis-like diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736709

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  18 in total

Review 1.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

2.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

3.  The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.

Authors:  Xi-Lei Zeng; Naresh R Thumati; Helen B Fleisig; Kyle R Hukezalie; Sharon A Savage; Neelam Giri; Blanche P Alter; Judy M Y Wong
Journal:  Hum Mol Genet       Date:  2011-11-04       Impact factor: 6.150

4.  The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA.

Authors:  Ryota Kurimoto; Tomoki Chiba; Yoshiaki Ito; Takahide Matsushima; Yuki Yano; Kohei Miyata; Yuka Yashiro; Tsutomu Suzuki; Kozo Tomita; Hiroshi Asahara
Journal:  EMBO J       Date:  2020-09-14       Impact factor: 11.598

Review 5.  Pseudouridine: still mysterious, but never a fake (uridine)!

Authors:  Felix Spenkuch; Yuri Motorin; Mark Helm
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique.

Authors:  Cecilia Martinez Campos; Kevin Tsai; David G Courtney; Hal P Bogerd; Christopher L Holley; Bryan R Cullen
Journal:  RNA       Date:  2021-08-10       Impact factor: 4.942

7.  A prion accelerates proliferation at the expense of lifespan.

Authors:  David M Garcia; Edgar A Campbell; Christopher M Jakobson; Mitsuhiro Tsuchiya; Ethan A Shaw; Acadia L DiNardo; Matt Kaeberlein; Daniel F Jarosz
Journal:  Elife       Date:  2021-09-15       Impact factor: 8.140

8.  Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA.

Authors:  Schraga Schwartz; Douglas A Bernstein; Maxwell R Mumbach; Marko Jovanovic; Rebecca H Herbst; Brian X León-Ricardo; Jesse M Engreitz; Mitchell Guttman; Rahul Satija; Eric S Lander; Gerald Fink; Aviv Regev
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

9.  Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.

Authors:  Rosario Machado-Pinilla; Jaime Carrillo; Cristina Manguan-Garcia; Leandro Sastre; Alexander Mentzer; B-W Gu; Philip J Mason; Rosario Perona
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

10.  Telomerase dysfunction and dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.